M. Suárez-Gea

发表

Causes of death in atrial fibrillation: Challenges and opportunities.

J. M. García-Pinilla, A. Gómez-Outes, M. Suárez-Gea, 2017, Trends in cardiovascular medicine.

Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups

A. Gómez-Outes, M. Suárez-Gea, A. Terleira-Fernández, 2013, Thrombosis.

Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta-analysis by geographic region with a focus on European patients.

A. Gómez-Outes, M. Suárez-Gea, A. Terleira-Fernández, 2016, British journal of clinical pharmacology.

Causes of Death in Anticoagulated Patients With Atrial Fibrillation.

A. Gómez-Outes, M. Suárez-Gea, A. Terleira-Fernández, 2016, Journal of the American College of Cardiology.

Causes of Death in Patients with Venous Thromboembolism Anticoagulated with Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2018, Seminars in Thrombosis and Hemostasis.

Ketomethylene and (cyanomethylene)amino pseudopeptide analogues of the C-terminal hexapeptide of neurotensin.

P. Suzdak, I. Gomez-Monterrey, M. García-López, 1995, Journal of medicinal chemistry.

Pseudopeptide CCK-4 analogues incorporating the Ψ[CH(CN)NH] peptide bond surrogate

M. García-López, R. González-Muñiz, M. Suárez-Gea, 1997 .

Discovery of anticoagulant drugs: a historical perspective.

R. Lecumberri, A. Gómez-Outes, E. Rocha, 2012, Current drug discovery technologies.

Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?

A. Gómez-Outes, M. Suárez-Gea, C. Pozo-Hernández, 2009, Journal of thrombosis and haemostasis : JTH.

Specific antidotes in development for reversal of novel anticoagulants: a review.

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2015, Recent patents on cardiovascular drug discovery.

Apixaban or enoxaparin for thromboprophylaxis.

A. Gómez-Outes, M. Suárez-Gea, C. Pozo-Hernández, 2009, The New England journal of medicine.

Rivaroxaban versus enoxaparin after total knee arthroplasty

A. Gómez-Outes, M. Suárez-Gea, C. Pozo-Hernández, 2009, The Lancet.

Pharmacotherapy for stroke prevention in nonvalvular atrial fibrillation: current strategies and future directions

J. M. García-Pinilla, A. Gómez-Outes, M. Suárez-Gea, 2022, Expert opinion on pharmacotherapy.

A. García‐Arieta, A. Gómez-Outes, M. Suárez-Gea, 2013 .

Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison

A. García‐Arieta, Covadonga Álvarez, S. Morales-Alcelay, 2013, European Journal of Clinical Pharmacology.

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons

A. Gómez-Outes, M. Suárez-Gea, A. Terleira‐Fernández, 2012, BMJ : British Medical Journal.

Branched peptides and conformationally constrained analogues from cyanomethyleneamino pseudopeptides

M. García-López, R. González-Muñiz, M. Suárez-Gea, 1996 .

Discovery methods of coagulation-inhibiting drugs

A. Gómez-Outes, M. Suárez-Gea, Minerva García-Fuentes, 2017, Expert opinion on drug discovery.

When are the cardiovascular and stroke risks too high? Pharmacotherapy for stroke prophylaxis

J. M. García-Pinilla, A. Gómez-Outes, M. Suárez-Gea, 2018, Expert opinion on pharmacotherapy.

Direct‐acting oral anticoagulants: pharmacology, indications, management, and future perspectives

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2015, European journal of haematology.

Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants.

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2021, Journal of the American College of Cardiology.

New parenteral anticoagulants in development

R. Lecumberri, A. Gómez-Outes, E. Rocha, 2011, Therapeutic advances in cardiovascular disease.

Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2014, Vascular health and risk management.

When and How to Use Reversal Agents for Direct Oral Anticoagulants?

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2023, Current Cardiology Reports.

Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2014, Thrombosis research.

Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism

M. Monreal, R. Lecumberri, A. Gómez-Outes, 2015, Journal of cardiovascular pharmacology and therapeutics.

Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients

R. Lecumberri, A. Gómez-Outes, E. Rocha, 2013, Vascular health and risk management.

Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison

A. García‐Arieta, Covadonga Álvarez, S. Morales-Alcelay, 2012, European Journal of Clinical Pharmacology.

Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products.

A. García‐Arieta, Covadonga Álvarez, S. Morales-Alcelay, 2012, International journal of pharmaceutics.

Substituted methyleneamino pseudopeptides: studies on the transformation of the Ψ[CH(CN)NH] peptide bond surrogate

M. García-López, M. Suárez-Gea, R. Herranz, 1994 .

A General Method for the Synthesis of Carbamoylmethyleneamino Pseudopeptides

M. Suárez-Gea, R. Herranz, M. Lopez, 1994 .

Vascular Health and Risk Management Dovepress Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism, with a Focus on Patients with Pulmonary Embolism: an Evidence-based Review

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2022 .

Causes of Death in Anticoagulated Patients With Atrial Fibrillation.

A. Gómez-Outes, M. Suárez-Gea, G. Calvo-rojas, 2016, Journal of the American College of Cardiology.